CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi

Journal of Immunology

Volumn 159, Issue 6, 1997, Pages 2840-2848

  Marietta, Eric V ^a   Weis, Janis J ^a   Weis, John H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; LIPOPOLYSACCHARIDE; LIPOPROTEIN; OMLA PROTEIN, BACTERIA; OUTER MEMBRANE PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BORRELIA BURGDORFERI; CELL CULTURE; FLOW CYTOMETRY; IMMUNOLOGY; MAST CELL; METABOLISM; MOUSE;

ANIMALS; ANTIGENS, CD28; BACTERIAL OUTER MEMBRANE PROTEINS; BORRELIA BURGDORFERI GROUP; CELLS, CULTURED; FLOW CYTOMETRY; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MAST CELLS; MICE;

EID: 0031571871     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kinet, J. P. 1989. The high-affinity receptor for IgE. Curr. Opin. Immunol. 2:499.
2. - bone marrow progenitors express FcγRII but do not express FcεRI until mast cell granule formation. J. Immunol. 154:355.
3. Johnson, A. R., T. E. Hugli, and H. J. Muller-Eberhard. 1975. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology 28:1067.
4. Rudd, C. E. 1996. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4:527.
5. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noëlle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
6. Gauchat, J. F., S. Henchoz, G. Mazzei, J. P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, F. R. Leopoldo, J. Thompson, K. Kishi, J. Butterfield, C. Dahinden, and J. Y. Bonnefoy. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340.
7. Ducharme, L., and J. H. Weis. 1992. Modulation of integrin expression during mast cell differentiation. Eur J. Immunol. 22:2603.
8. Smith, T. J., L. A. Ducharme, S. K. Shaw, C. M. Parker, M. B. Brenner, P. J. Kilshaw, and J. H. Weis. 1994. Murine M290 integrin expression modulated by mast cell activation. Immunity 1:393.
9. Ihle, J. N., J. Keller, S. Oroszzalan, L. E. Henderson, T. D. Copeland, F. Fitch, M. B. Prystowsky, E. Goldwasser, J. W. Schrader, E. Paraszynski, M. Dy, and B. Lebel. 1983. Biological properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P cell-stimulating activity and histamine-producing activity. J. Immunol. 131:282.
10. Metcalfe, D., C. G. Begley, N. A. Johnson, N. A. Nicola, A. F. Lopez, and D. J. Wilson. 1986. Effects of purified bacterially synthesized murine Multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood 68:46.
11. Razin, E., K. B. Leslie, and J. W. Schrader. 1991. Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. J. Immunol. 146:981.
12. Tertian, G., Y.-P. Yung, D. Guy-Grand, and M. A. S. Moore. 1981. Long term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique. J. Immunol. 127:788.
13. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2,3, 4, or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
14. Marietta, E., Y. Chen, and J. H. Weis. 1996. Modulation of expression of the anti-inflammatory cytokines IL-13 and IL-10 by IL-3 and mast cell activation. Eur. J. Immunol. 26:49.
15. + cells developing in IL-3-dependent murine bone marrow-derived cell cultures. J. Immunol. 151:4950.